The David H. Koch Institute for Integrative Cancer Research at MITThe David H. Koch Institute for Integrative Cancer Research at MIT

Massachusetts Institute of Technology

National Cancer Institute Cancer Center

Science + Engineering... Conquering Cancer Together

Summer Symposium 2018

Breakthrough Cancer Nanotechnologies

On June 15, 2018, MIT’s Koch Institute for Integrative Cancer Research will present its 17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies. Nanomedicine is a converging field of study in biology and engineering where scientists work at the molecular level to engineer innovative approaches to better detect, monitor, and treat cancer. Experts will discuss how nanotechnology can provide rapid and sensitive detection of cancer, as well as generate entirely novel and highly effective therapeutic agents. The symposium will also feature an industry panel to discuss the impact of nanomedicine on the future of cancer care.

CLICK HERE TO REGISTER

Speakers


Daniel Anderson

Nanoparticle Formulations for RNA Therapy and Gene Editing

Daniel Anderson, PhD
Samuel A. Goldblith Professor of Applied Biology, MIT
Associate Professor, Chemical Engineering and Institute for Medical Engineering and Science, MIT
Member, Koch Institute, MIT

Rashid Bashir

Micro and Nanotechnologies for Analysis of Tissues and Molecules

Rashid Bashir, PhD
Executive Associate Dean and Chief Diversity Officer, Carle Illinois College of Medicine
Grainger Distinguished Chair in Engineering, Professor of Bioengineering, Electrical and Computer Engineering, Mechanical Science and Engineering, Materials Science and Engineering, and Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign

Angela Belcher

New Approaches for Finding Tiny Tumors: Towards Early Detection and Treatment of Ovarian Cancer

Angela Belcher, PhD
James Mason Crafts Professor and Professor of Biological Engineering, MIT
Member, Koch Institute, MIT

Sangeeta Bhatia

Protease Nanosensors for Cancer Detection, Classification and Monitoring

Sangeeta Bhatia, MD, PhD
Director, Marble Center for Cancer Nanomedicine
John J. and Dorothy Wilson Professor of Health Sciences and Technology and of Electrical Engineering and Computer Science, MIT
Member, Koch Institute, MIT
Investigator, Howard Hughes Medical Institute

Vladimir Bulović, PhD

Nanoscale Discoveries for Transformative Breakthroughs

Vladimir Bulović, PhD
Director, MIT.nano
Associate Dean for Innovation, MIT School of Engineering
Fariborz Maseeh (1990) Professor of Emerging Technology, Department of Electrical Engineering and Computer Science (EECS), MIT

Mark E. Davis, PhD

Designing Nanoparticles to Safely Cross the Blood-Brain Barrier for Treating Brain Cancers

Mark E. Davis, PhD  
Warren and Katharine Schlinger Professor of Chemical Engineering, California Institute of Technology
Member of the City of Hope Comprehensive Cancer Center
Member of the UCLA Jonsson Comprehensive Cancer Center

Sanjiv Sam Gambhir, MD, PhD

Bubble Based Nanodiagnostics

Sanjiv Sam Gambhir, MD, PhD  
Virginia and D.K. Ludwig Professor for Clinical Investigation in Cancer Research, Professor of Bioengineering, Professor of Materials Science and Engineering, Stanford University

James R. Heath

A Molecular View of Immuno-Oncology

James R. Heath, PhD
President and Professor, Institute for Systems Biology
Professor of Molecular and Medical Pharmacology, UCLA

Suzie H. Pun

Modulating Tumor-Associated Macrophage

Suzie H. Pun, PhD
Robert F. Rushmer Professor of Bioengineering, Adjunct Professor of Chemical Engineering, University of Washington

Ralph Weissleder

Developing Next Generation Diagnostics for Cancer

Ralph Weissleder, MD, PhD
Thrall Professor of Radiology and Professor of Systems Biology, Harvard Medical School
Director of the Center for Systems Biology at Massachusetts General Hospital

 

Panelists: Translation of Nanomedicine to Patients


Noubar Afeyan

 

Noubar Afeyan, PhD
Founder and CEO, Flagship Pioneering
 

Michelle S. Bradbury, MD, PhD

 

Michelle S. Bradbury, MD, PhD
Co-Director, MSK-Cornell Center for Translation of Cancer Nanomedicines & Director, Intraoperative Imaging Program
Member, Molecular Pharmacology Program, Sloan Kettering Institute
Attending, Radiology, Memorial Sloan Kettering Cancer Center
Professor, Gerstner Sloan Kettering Graduate School of Biomedical Sciences & Weill Medical College of Cornell University

Paula Hammond

 

Paula Hammond, PhD
Head, Department of Chemical Engineering, MIT
David H. Koch Professor of Engineering, MIT
Member, Koch Institute, MIT

Robert Langer

 

Robert Langer, ScD
David H. Koch Institute Professor
Member, Koch Institute, MIT

John Maraganore

 

John Maraganore, PhD
CEO and Director, Alnylam

Cristianne Rijcken

 

Cristianne Rijcken, PhD
Founder and Chief Scientific Officer, Cristal Therapeutics

Rebecca Spalding

Moderator

Rebecca Spalding
Biotech Reporter, Bloomberg

 

Thank you to our sponsors


Diamond

Thermo Fisher Scientific

Gold

Johnson & Johnson Innovation
Sanofi Oncology

Silver

Agilent
Alnylam Pharmaceuticals
Bayer
Flagship Pioneering
Lumicell
Novartis
Takeda Pharmaceuticals

Bronze

Amgen
Cell Signaling Technology, Inc.
Nano Letters
Surefire Medical, Inc.

Vendors

Cell Press
Cell Signaling Technology, Inc.
Fisher Scientific
Qiagen
Transnetyx